Evidence map›Paper›PMID 37994182›Full record

ArticleThe Medical journal of Australia2024

Disruption of gender-affirming health care, and COVID-19 illness, testing, and vaccination among trans Australians during the pandemic: a cross-sectional survey.

Sav Zwickl, Tomi Ruggles, Alex Fq Wong, Ariel Ginger, Lachlan M Angus, Kalen Eshin, Teddy Cook, Ada S Cheung

Open access · hybridAbstract read
In one paragraph

Article in The Medical journal of Australia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sav ZwicklThe University of Melbourne, Melbourne, VIC.
Tomi RugglesThe University of Melbourne, Melbourne, VIC.
Alex Fq WongThe University of Melbourne, Melbourne, VIC.
Ariel GingerThe University of Melbourne, Melbourne, VIC.
Lachlan M AngusThe University of Melbourne, Melbourne, VIC.
Kalen EshinLa Trobe University, Melbourne, VIC.
Teddy CookACON, Sydney, NSW.
Ada S CheungThe University of Melbourne, Melbourne, VIC.ORCID 0000-0001-5257-5525
The University of Melbourne · AUAustralian Centre for Advanced Computing and Communications (Australia) · AULa Trobe University · AU

Funding

National Health and Medical Research Council 2008956
6 · The paper itself

Abstract

objectivesTo assess rates of disruption of gender-affirming health care, of coronavirus disease 2019 (COVID-19) illness, testing, and vaccination, and of discrimination in health care among Australian trans people during the COVID-19 pandemic. DESIGN,

settingOnline cross-sectional survey (1-31 May 2022); respondents were participants recruited by snowball sampling for TRANSform, an Australian longitudinal survey-based trans health study, 1 May - 30 June 2020.

participantsPeople aged 16 years or older, currently living in Australia, and with a gender different to their sex recorded at birth.

main outcome measuresProportions of respondents who reported disruptions to gender-affirming health care, COVID-19 illness, testing, and vaccination, and positive and negative experiences during health care.

resultsOf 875 people invited, 516 provided valid survey responses (59%). Their median age was 33 years (interquartile range, 26-45 years); 193 identified as women or trans women (37%), 185 as men or trans men (36%), and 138 as non-binary (27%). Of 448 respondents receiving gender-affirming hormone therapy, 230 (49%) reported disruptions to treatment during the pandemic; booked gender-affirming surgery had been cancelled or postponed for 37 of 85 respondents (44%). Trans-related discrimination during health care was reported by a larger proportion of participants than in a pre-pandemic survey (56% v 26%). COVID-19 was reported by 132 respondents (26%), of whom 49 reported health consequences three months or more after the acute illness (37%; estimated Australian rate: 5-10%). Three or more COVID-19 vaccine doses were reported by 448 participants (87%; Australian adult rate: 70%).

conclusionsHigh rates of COVID-19 vaccination among the trans people we surveyed may reflect the effectiveness of LGBTIQA+ community-controlled organisation vaccination programs and targeted health promotion. Training health care professionals in inclusive services for trans people could improve access to appropriate health care and reduce discrimination.

Indexed as

Australasian PeopleCOVID-19Gender-Affirming CareVaccinationAdultAustraliaCOVID-19 VaccinesCross-Sectional StudiesDelivery of Health CareFemaleHumansMaleMiddle AgedPandemicsTransgender PersonsCOVID-19 VaccinesCOVID-19Gender identityHealthcare disparitiesVaccination

Identifiers

PMID37994182
PMCPMC10952718
OpenAlexW4388952299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.